New research uncovers biological drivers of heart disease risk
Plant-based swaps may cut diabetes and heart disease risk, major review finds
Findings from a phase 1 trial show that a single dose of an experimental therapy produced greater than 94% reductions in blood levels of lipoprotein(a), a key driver of heart disease risk, with the results lasting for nearly a year